Minapharm Pharmaceuticals (MIPH) Key Statistics
26 reported figures for Minapharm Pharmaceuticals — valuation multiples, the latest fiscal year's income statement, balance-sheet totals, growth rates and technical readings. Figures with no reported value are omitted rather than shown as zero.
Valuation
- Market cap
- EGP 8.47B
- P/E (trailing)
- 1,254.18
- P/B
- 1.41
- Dividend yield (FY 2025)
- 0.33%
Income (latest fiscal year)
- Revenue
- EGP 6.44B
- Net income
- EGP 36.62M
- EBITDA
- EGP 1.21B
- Free cash flow
- EGP -259.11M
- Profit margin
- 0.57%
Balance sheet
- Total assets
- EGP 13.15B
- Total debt
- EGP 4.52B
- Book value
- EGP 6.25B
Growth
- Revenue growth
- 14.97%
- Profit growth
- -76.14%
- EPS growth
- -94.84%
Per share
- EPS (fiscal year)
- 0.6
- Book value per share
- 530.56
- Dividend per share
- 2.5
- Return on equity
- 0.7%
- Return on assets
- 0.29%
Technical
- RSI (14)
- 44.6
- 50-day moving average
- EGP 795.88
- 200-day moving average
- EGP 620.17
- Beta (1Y)
- 0.7
Shares
- Shares outstanding
- 11.78M
- Free float
- 42.13%
Fiscal-year figures are as the company last reported them; technical readings refresh with market data.